36 related articles for article (PubMed ID: 22451308)
1. Overexpression of human wild-type amyloid-β protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells.
Wan L; Nie G; Zhang J; Zhao B
J Alzheimers Dis; 2012; 30(3):523-30. PubMed ID: 22451308
[TBL] [Abstract][Full Text] [Related]
2. Expression and Localization of AβPP in SH-SY5Y Cells Depends on Differentiation State.
Riegerová P; Brejcha J; Bezděková D; Chum T; Mašínová E; Čermáková N; Ovsepian SV; Cebecauer M; Štefl M
J Alzheimers Dis; 2021; 82(2):485-491. PubMed ID: 34057078
[TBL] [Abstract][Full Text] [Related]
3. Ethyl maltol disrupt iron homeostasis in SH-SY5Y neuroblastoma cell line.
Sun Y; Bressler J
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23504. PubMed ID: 37606557
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.
Habib LK; Lee MT; Yang J
J Biol Chem; 2010 Dec; 285(50):38933-43. PubMed ID: 20923778
[TBL] [Abstract][Full Text] [Related]
5. Protection of Iron-Induced Oxidative Damage in Neuroblastoma (SH-SY5Y) Cells by Combination of 1-(N-Acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one and Green Tea Extract.
Chansiw N; Kulprachakarn K; Paradee N; Prommaban A; Srichairatanakool S
Bioinorg Chem Appl; 2021; 2021():5539666. PubMed ID: 33986790
[TBL] [Abstract][Full Text] [Related]
6. Erratum to: Differential accumulation of secreted AbetaPP metabolites in ocular fluids.
J Alzheimers Dis; 2024; 97(2):975-976. PubMed ID: 38250787
[No Abstract] [Full Text] [Related]
7. Exploring Whether Iron Sequestration within the CNS of Patients with Alzheimer's Disease Causes a Functional Iron Deficiency That Advances Neurodegeneration.
LeVine SM; Tsau S; Gunewardena S
Brain Sci; 2023 Mar; 13(3):. PubMed ID: 36979320
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity.
Ibrahim Fouad G; El-Sayed SAM; Mabrouk M; Ahmed KA; Beherei HH
Neurotox Res; 2022 Oct; 40(5):1479-1498. PubMed ID: 35969308
[TBL] [Abstract][Full Text] [Related]
9. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.
Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ
Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024
[TBL] [Abstract][Full Text] [Related]
10. The essential elements of Alzheimer's disease.
Lei P; Ayton S; Bush AI
J Biol Chem; 2021; 296():100105. PubMed ID: 33219130
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the Iron Side of Stroke: Neurodegeneration at the Crossroads Between Iron Dyshomeostasis, Excitotoxicity, and Ferroptosis.
DeGregorio-Rocasolano N; Martí-Sistac O; Gasull T
Front Neurosci; 2019; 13():85. PubMed ID: 30837827
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.
Uranga RM; Salvador GA
Oxid Med Cell Longev; 2018; 2018():2850341. PubMed ID: 29581821
[TBL] [Abstract][Full Text] [Related]
13. The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons.
Ji C; Steimle BL; Bailey DK; Kosman DJ
Cell Mol Neurobiol; 2018 May; 38(4):941-954. PubMed ID: 29177638
[TBL] [Abstract][Full Text] [Related]
14. Bioavailable Trace Metals in Neurological Diseases.
Poujois A; Devedjian JC; Moreau C; Devos D; Chaine P; Woimant F; Duce JA
Curr Treat Options Neurol; 2016 Oct; 18(10):46. PubMed ID: 27682263
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.
Sun Y; Pham AN; Waite TD
J Neurochem; 2016 Jun; 137(6):955-68. PubMed ID: 26991725
[TBL] [Abstract][Full Text] [Related]
16. β-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin.
Wong BX; Tsatsanis A; Lim LQ; Adlard PA; Bush AI; Duce JA
PLoS One; 2014; 9(12):e114174. PubMed ID: 25464026
[TBL] [Abstract][Full Text] [Related]
17. The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders.
Wong BX; Duce JA
Front Pharmacol; 2014; 5():81. PubMed ID: 24795635
[TBL] [Abstract][Full Text] [Related]
18. Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome.
Cozzi A; Santambrogio P; Privitera D; Broccoli V; Rotundo LI; Garavaglia B; Benz R; Altamura S; Goede JS; Muckenthaler MU; Levi S
J Exp Med; 2013 Aug; 210(9):1779-91. PubMed ID: 23940258
[TBL] [Abstract][Full Text] [Related]
19. A delicate balance: Iron metabolism and diseases of the brain.
Hare D; Ayton S; Bush A; Lei P
Front Aging Neurosci; 2013; 5():34. PubMed ID: 23874300
[TBL] [Abstract][Full Text] [Related]
20. PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE).
Lahiri DK; Maloney B; Rogers JT; Ge YW
BMC Genomics; 2013 Jan; 14():68. PubMed ID: 23368879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
